Intelligent Bio Solutions Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Intelligent Bio Solutions Inc.'s yearly results (2023–2026), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Shareholder Slice Ratio: Share count rose 14,871% in 3 years, so each share's slice of the company became smaller. Bigger rise in share count than 96% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Jun 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-53.8×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 73% of Healthcare companies in United States.
Cash Locked Ratio
$25For every $100 of sales, $25 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $49 tied up three years earlier.
More money tied up than 52% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
2/3 · 1/3Sales grew in 2 of the last 3 years; profit grew in 1 of 3.
Steadier than 50% of Healthcare companies in United States.
Growth Efficiency Ratio
−$61Sales grew 235% in 3 years, but profit fell: $61 less profit per $100 of extra sales.
Lower than 84% of Healthcare companies in United States.
Asset Productivity Ratio
+235% / +15%In 3 years sales changed by +235% while total assets changed by +15%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-81.1×Operating cash was negative last year, while some debt falls due within a year.
Lower than 80% of Healthcare companies in United States.
Cash Cushion Ratio
+39%Cash, after subtracting all debt, equals 39% of its market value (net cash).
Higher than 73% of Healthcare companies in United States.
Tangible Assets Ratio
77%Of every $100 the company owns, $77 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 55% of Healthcare companies in United States.
Tangible Net Worth Ratio
49%Of every $100 of net worth, $49 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 53% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Intelligent Bio Solutions Inc. made a loss over the last year. Intelligent Bio Solutions Inc. owes $0.56 for every $1 it owns. Intelligent Bio Solutions Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Jun 2026.
P/E ratio
LossIntelligent Bio Solutions Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
1.01The share price is 1.01 times Intelligent Bio Solutions Inc.'s book value per share, lower than 78% of Healthcare companies in United States.
Market cap
$6 MThe total market value of all of Intelligent Bio Solutions Inc.'s shares at today's price (share price × number of shares), smaller than 92% of Healthcare companies in United States. PosiCap size class: Nano Cap.
Net worth (book value)
$6 MWhat Intelligent Bio Solutions Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$1.66Net worth divided by the number of shares. The share price of $1.68 is 1.0 times this, which is the P/B above.
Return on equity (ROE)
-307.7%Intelligent Bio Solutions Inc. lost 307.7% of its shareholders' money over the last year, lower than 88% of Healthcare companies in United States.
Owes vs Owns
0.56×Intelligent Bio Solutions Inc. owes $0.56 for every $1 it owns (moderate), higher than 61% of Healthcare companies in United States.
Dividend yield
NoneIntelligent Bio Solutions Inc. does not currently pay a dividend.
Revenue growth
+38%Revenue rose 38% in the year to Jun 2026, and grew 50% a year on average over 3 years.
Profit growth
LossIntelligent Bio Solutions Inc. made a loss in each of the last two years.
Profit margin
-294.9%Intelligent Bio Solutions Inc. lost $295 for every $100 of revenue.
Interest cover
Not coveredIntelligent Bio Solutions Inc.'s operating profit did not cover its interest costs in the year to Jun 2026.
Cash vs debt
Net cashIntelligent Bio Solutions Inc. held $2 M more cash than debt (net cash) at Jun 2026.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Intelligent Bio Solutions Inc.: $6 M ÷ $6 M (30 Jun 2026) = 1.0.
What is Intelligent Bio Solutions Inc.'s return on equity?
Intelligent Bio Solutions Inc. lost 307.7% of its shareholders' money over the last year, lower than 88% of Healthcare companies in United States.
How much does Intelligent Bio Solutions Inc. owe compared with what it owns?
Intelligent Bio Solutions Inc. owes $0.56 for every $1 it owns (moderate), higher than 61% of Healthcare companies in United States.
Does Intelligent Bio Solutions Inc. pay a dividend?
No. Intelligent Bio Solutions Inc. does not currently pay a dividend.
Is Intelligent Bio Solutions Inc.'s revenue growing?
Revenue rose 38% in the year to Jun 2026, and grew 50% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.